Results by group20

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 20

Outcome	Group	Category	Value	Spread	Units
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC last (ng.h/mL) -Day 1 20 mg n=16	78	Standard Deviation 44.9	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC last (ng.h/mL) -Day 1 40 mg n=24	140	Standard Deviation 65.4	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC last (ng.h/mL) -Day 1 80 mg n=54	300	Standard Deviation 140	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-24 (ng.h/mL) -D 10/12 20 mg n=16	115	Standard Deviation 72.2	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-24 (ng.h/mL) -D10/12 40 mg n=21	154	Standard Deviation 67.4	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-24 (ng.h/mL) -D10/12 80 mg n=17	387	Standard Deviation 194	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-24 (ng.h/mL) -D10/12 120 mg n=16	494	Standard Deviation 271	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-24 (ng.h/mL) -D 10/12 160 mg n=13	590	Standard Deviation 227	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-∞(ng.h/mL) -D 1 20 mg n=16	83.8	Standard Deviation 48.3	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-∞(ng.h/mL) -D 1 40 mg n=19	153	Standard Deviation 69.8	ng.h/mL
Lurasidone Primary Pharmacokinetic Parameters	Lurasidone Oral Tablets	AUC0-∞(ng.h/mL) -D 1 80 mg n=50	328	Standard Deviation 163	ng.h/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-Day 1 20 mg n=16	24.4	Standard Deviation 14.1	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-Day 1 40 mg n=24	38.3	Standard Deviation 22.4	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-Day 1 80 mg n=55	68.2	Standard Deviation 37.5	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-D10/12 20 mg n=16	30	Standard Deviation 18	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-D10/12 40 mg n=21	36.2	Standard Deviation 17.5	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-D10/12 80 mg n=17	80	Standard Deviation 59.6	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-D10/12 120 mg n=16	94.2	Standard Deviation 46.6	ng/mL
Lurasidone Peak Serum Concentration (Cmax)	Lurasidone Oral Tablets	Cmax (ng/mL)-D10/12 160 mg n=13	99.7	Standard Deviation 44.3	ng/mL
Number of Participants With Serious Adverse Events and Non-serious Adverse Events	Lurasidone Oral Tablets		105		participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01620060/results

API reference For AI assistants